JASPER THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.82 USD | -4.39% |
|
+3.92% | +215.83% |
| May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
| May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 24.52 | 30.00 | 29.50 |
| Spread/Res. | +1.63% | -16.94% | -15.53% |
| Spread/Supp. | +22.15% | +130.73% | +96.21% |
| Support | 20.40 | 10.80 | 12.70 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- JSPR Stock
- Charts Jasper Therapeutics, Inc.
